Gainers
- Omega Therapeutics OMGA shares increased by 99.6% to $5.45 during Thursday's regular session. The market value of their outstanding shares is at $300.5 million.
- Avenue Therapeutics ATXI shares increased by 56.08% to $0.27. The company's market cap stands at $3.6 million.
- Dyne Therapeutics DYN stock rose 30.28% to $19.24. The market value of their outstanding shares is at $1.1 billion.
- Adicet Bio ACET shares moved upwards by 25.0% to $2.2. The company's market cap stands at $94.9 million.
- Bright Health Gr BHG stock increased by 24.15% to $11.36. The company's market cap stands at $90.6 million.
- Werewolf Therapeutics HOWL shares moved upwards by 20.22% to $5.23. The market value of their outstanding shares is at $189.2 million.
Losers
- SELLAS Life Sciences Gr SLS stock decreased by 35.7% to $0.58 during Thursday's regular session. The company's market cap stands at $18.6 million.
- Relmada Therapeutics RLMD stock declined by 30.69% to $3.14. The market value of their outstanding shares is at $94.5 million.
- LifeMD LFMD shares declined by 29.99% to $5.44. The company's market cap stands at $213.2 million.
- OPKO Health OPK stock declined by 28.13% to $1.08. The company's market cap stands at $833.4 million.
- Jin Medical International ZJYL stock declined by 25.83% to $149.09. The company's market cap stands at $1.1 billion.
- ABVC BioPharma ABVC stock fell 20.37% to $1.54. The company's market cap stands at $11.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ACETAdicet Bio Inc
$0.92002.94%
ATXIAvenue Therapeutics Inc
$1.79-0.56%
DYNDyne Therapeutics Inc
$24.492.43%
HOWLWerewolf Therapeutics Inc
$1.56-0.64%
LFMDLifeMD Inc
$4.90-1.80%
OMGAOmega Therapeutics Inc
$0.83022.37%
OPKOPKO Health Inc
$1.51-%
RLMDRelmada Therapeutics Inc
$0.3582-5.64%
SLSSELLAS Life Sciences Group Inc
$0.93012.31%
ZJYLJin Medical International Ltd
$0.999911.1%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in